Dermapharm

Dermapharm successfully acquires C? Group

Gr¸nwald, 31 January 2022 - Dermapharm Holding SE ("Dermapharm"), a fast-growing manufacturer of branded pharmaceuticals, has successfully completed the acquisition of the C≥ Cannabinoid Compound Company GmbH ("C≥ Group").
Dermapharm Holding SE Lil-Dagover-Ring 7 82031 Grünwald Germany

+49 (89) 6 41 86-0